Company Search:
Advanced Search
Sponsored Links
Dae Han New Pharm Co., Ltd. Company Snapshot
Dae Han New Pharm Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dae Han New Pharm Co., Ltd. with three other companies in this sector in KOREA (SOUTH) : Hyundai Pharmaceutical Company Limited (2019 sales of 134.92 billion Korean Won [US$119.14 million] of which 81% was Pharmaceutical), Reyon Pharmaceutical Co Ltd (131.56 billion Korean Won [US$116.17 million] of which 33% was other finished goods), and Theragen Etex Co Limited (138.08 billion Korean Won [US$121.93 million] of which 86% was Pharmaceutical Business Segment).

Sales Analysis. Dae Han New Pharm Co., Ltd. reported sales of 134.10 billion Korean Won (US$118.41 million) for the year ending December of 2019. This represents an increase of 12.2% versus 2018, when the company's sales were 119.53 billion Korean Won . Sales of Merchandise saw an increase that was more than double the company's growth rate: sales were up 41.5% in 2019, from 18.26 billion Korean Won to 25.85 billion Korean Won .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dae Han New Pharm Co., Ltd.
  Stock Performance Chart for Dae Han New Pharm Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 11,950
(Figures in Korean Won )
1 Week -8.1%   13 Weeks -5.2%  
4 Weeks 3.9%   52 Weeks 1.7%  
Dae Han New Pharm Co., Ltd. Key Data:
  Ticker: 054670 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 134,097,440,468
(Year Ending Jan 2020).
Employees: 332
  Currency: Korean Won Market Cap: 167,721,703,550
  Fiscal Yr Ends: December Shares Outstanding: 14,035,289
  Share Type: Common Closely Held Shares: 5,755,792
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.